Found: 49
Select item for more details and to access through your institution.
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 10, p. 1479, doi. 10.3390/healthcare11101479
- By:
- Publication type:
- Article
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11157-0
- By:
- Publication type:
- Article
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4358, doi. 10.3390/ijms23084358
- By:
- Publication type:
- Article
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 486, doi. 10.3390/ijms22020486
- By:
- Publication type:
- Article
Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3900, doi. 10.3390/ijms21113900
- By:
- Publication type:
- Article
Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3622, doi. 10.3390/ijms21103622
- By:
- Publication type:
- Article
Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5459, doi. 10.3390/ijms20215459
- By:
- Publication type:
- Article
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 14, p. 3548, doi. 10.3390/ijms20143548
- By:
- Publication type:
- Article
AIPSS‐MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib.
- Published in:
- Cancer Reports, 2023, v. 6, n. 10, p. 1, doi. 10.1002/cnr2.1881
- By:
- Publication type:
- Article
The Role of Inflammation and Inflammasome in Myeloproliferative Disease.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2334, doi. 10.3390/jcm9082334
- By:
- Publication type:
- Article
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 2, p. 259, doi. 10.3390/life13020259
- By:
- Publication type:
- Article
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.819136
- By:
- Publication type:
- Article
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 5, p. 689, doi. 10.1111/bjh.13198
- By:
- Publication type:
- Article
Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome.
- Published in:
- Journal of Clinical Apheresis, 2016, v. 31, n. 5, p. 443, doi. 10.1002/jca.21434
- By:
- Publication type:
- Article
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.748766
- By:
- Publication type:
- Article
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 3043, doi. 10.1007/s00277-024-05752-6
- By:
- Publication type:
- Article
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 6, p. 1009, doi. 10.1007/s00277-018-3276-y
- By:
- Publication type:
- Article
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 14, p. 4273, doi. 10.3390/jcm13144273
- By:
- Publication type:
- Article
Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 578, doi. 10.3390/jcm12020578
- By:
- Publication type:
- Article
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 5, p. 696, doi. 10.3390/biom10050696
- By:
- Publication type:
- Article
Target Therapy for Extramedullary Relapse of FLT3 -ITD Acute Myeloid Leukemia: Emerging Data from the Field.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092186
- By:
- Publication type:
- Article
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1173, doi. 10.3390/cancers14051173
- By:
- Publication type:
- Article
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 1999, doi. 10.3390/cancers12081999
- By:
- Publication type:
- Article
Ixazomib Improves Bone Remodeling and Counteracts Sonic Hedgehog Signaling Inhibition Mediated by Myeloma Cells.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 323, doi. 10.3390/cancers12020323
- By:
- Publication type:
- Article
Management of polycythemia vera: A survey of treatment patterns in Italy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 161, doi. 10.1111/ejh.13889
- By:
- Publication type:
- Article
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.604143
- By:
- Publication type:
- Article
Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 3, p. 207, doi. 10.1111/ejh.12325
- By:
- Publication type:
- Article
The first description of a singular case of synchronous chronic myelomonocytic leukemia and diffuse large b‐cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e195, doi. 10.1016/j.clml.2019.09.325
- By:
- Publication type:
- Article
TLR4 signaling drives mesenchymal stromal cells (MSC) commitment to promote tumor microenvironment transformation in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e90, doi. 10.1016/j.clml.2019.09.147
- By:
- Publication type:
- Article
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment.
- Published in:
- Antioxidants, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/antiox11040767
- By:
- Publication type:
- Article
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
- By:
- Publication type:
- Article
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00057
- By:
- Publication type:
- Article
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 10, p. N.PAG, doi. 10.1038/s41419-019-1959-5
- By:
- Publication type:
- Article
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158392
- By:
- Publication type:
- Article
Comparison of JAK2<sup>V617F</sup> -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 4, p. 180, doi. 10.1002/hon.1022
- By:
- Publication type:
- Article
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 10, p. 1114, doi. 10.3390/cells8101114
- By:
- Publication type:
- Article
Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 9, p. 1142, doi. 10.1002/jcph.2052
- By:
- Publication type:
- Article
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 3, p. 405, doi. 10.1046/j.1365-2141.2003.04106.x
- By:
- Publication type:
- Article
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1141610
- By:
- Publication type:
- Article
In vitro Apoptotic Response of Freshly Isolated Chronic Myeloid Leukemia Cells to all-trans Retinoic Acid and Cytosine Arabinoside.
- Published in:
- Acta Haematologica, 2000, v. 104, n. 2/3, p. 57, doi. 10.1159/000039753
- By:
- Publication type:
- Article
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01186
- By:
- Publication type:
- Article
Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00699
- By:
- Publication type:
- Article
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4970, doi. 10.3390/curroncol29070395
- By:
- Publication type:
- Article